Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study

MLA

Lionel Ades, et al. “Prognostic Impact of JAK2V617F Mutation in Myelodysplatic Syndromes: A Matched Case Control Study.” Leukemia Research Reports, no. 2, pp. 64–66. EBSCOhost, https://doi.org/10.1016/j.lrr.2013.06.003. Accessed 12 Dec. 2024.

APA

Lionel Ades, Véronique Mansat-De Mas, Benoit de Renzis, Zahia Azgui, Laurent Knoops, Odile Beyne-Rauzy, Pierre Fenaux, Aurélie Cabrespine, Jean-Jacques Kiladjian, & Eric Wattel. (n.d.). Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study. Leukemia Research Reports, 2, 64–66. https://doi.org/10.1016/j.lrr.2013.06.003

Chicago

Lionel Ades, Véronique Mansat-De Mas, Benoit de Renzis, Zahia Azgui, Laurent Knoops, Odile Beyne-Rauzy, Pierre Fenaux, Aurélie Cabrespine, Jean-Jacques Kiladjian, and Eric Wattel. 2024. “Prognostic Impact of JAK2V617F Mutation in Myelodysplatic Syndromes: A Matched Case Control Study.” Leukemia Research Reports, no. 2: 64–66. Accessed December 12. doi:10.1016/j.lrr.2013.06.003.